AIX Ventures logo

AIX Ventures

North America, California, United States, San Francisco

Description

AIX Ventures is a specialized venture capital firm based in San Francisco, exclusively focused on investing in early-stage artificial intelligence companies. Founded by experienced AI practitioners, the firm positions itself as a strategic partner to founders building the next generation of AI-native applications and foundational technologies. Their investment thesis centers on identifying disruptive AI solutions across various sectors, from enterprise software to consumer applications, emphasizing teams with deep technical expertise and a clear vision for AI's transformative potential.

The firm closed its debut fund, AIX Ventures Fund I, with $100 million in capital commitments in February 2023. This substantial fund allows AIX Ventures to provide meaningful early-stage capital to promising startups. They typically operate at the pre-seed and seed stages, often serving as the first institutional investor. Their approach extends beyond capital, offering portfolio companies access to a robust network of AI experts, industry leaders, and potential customers, along with operational guidance to accelerate growth and product development.

AIX Ventures aims to be a hands-on partner, leveraging its team's operational experience in AI to support founders through critical phases of development. They prioritize companies that demonstrate strong technical innovation, a clear market need, and the potential for significant scale. With a portfolio that already includes over 30 investments, AIX Ventures has quickly established itself as a prominent player in the highly competitive AI venture landscape, backing companies that are shaping the future of AI.

Investor Profile

AIX Ventures has backed more than 34 startups, with 9 new investments in the last 12 months alone. The firm has led 10 rounds, about 29% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Pre Seed, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Canada, Germany.
  • Strong thematic focus on Artificial Intelligence (AI), Software, Biotechnology.
  • Led 7 rounds in the past year.
  • Typical check size: $500K – $2M.

Stage Focus

  • Seed (65%)
  • Pre Seed (12%)
  • Series A (12%)
  • Series C (9%)
  • Series Unknown (3%)

Country Focus

  • United States (79%)
  • Canada (6%)
  • Germany (6%)
  • Switzerland (3%)
  • United Kingdom (3%)
  • Israel (3%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Software
  • Biotechnology
  • Machine Learning
  • Information Technology
  • Generative Ai
  • Health Care
  • E-commerce
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AIX Ventures frequently co-invest with?

TH
North America, California, United States, Menlo Park
Co-Investments: 2
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 2
Virtue
North America, Texas, United States, Austin
Co-Investments: 2
8VC
North America, California, United States, San Francisco
Co-Investments: 2
Index Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Insight Partners
North America, New York, United States, New York
Co-Investments: 2
Page One Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Radical Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 2
Air Street Capital
Europe, England, United Kingdom, London
Co-Investments: 2

Which angels does AIX Ventures often collaborate with?

Marc G. Bellemare
North America, Quebec, Canada, Montreal
Shared Deals: 1
Yoshua Bengio
North America, Quebec, Canada, Montréal
Shared Deals: 1
JD
North America, California, United States, Palo Alto
Shared Deals: 5
Hugo Larochelle
North America, Quebec, Canada, Sherbrooke
Shared Deals: 1
AM
North America, New York, United States, New York
Shared Deals: 1
AL
Europe, Niedersachsen, Germany, Hanover
Shared Deals: 1
OP
North America, New York, United States, New York
Shared Deals: 1
KD
North America, California, United States, Oakland
Shared Deals: 1
MA
Asia, Ar Riyad, Saudi Arabia, Riyadh
Shared Deals: 1
RK
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by AIX Ventures?

Proxima

New York, New York, United States

Proxima Bio develops programmable medicines that modulate protein interactions to address disease processes.

Alternative MedicineArtificial Intelligence (AI)BiotechnologyClinical TrialsLife ScienceMachine Learning
SeedJan 13, 2026
Amount Raised: $86,264,999
WearLinq

San Francisco, California, United States

WearLinq is a provider of wearable health monitoring and diagnosis solutions.

ManufacturingMedicalMedical Device
Series ADec 17, 2025
Amount Raised: $14,000,000
Greenshoe

New York, New York, United States

Greenshoe is an AI-powered platform that streamlines SEC disclosure drafting, analysis, and benchmarking for enhanced productivity.

Artificial Intelligence (AI)ComplianceLegal Tech
SeedNov 13, 2025
Amount Raised: $3,000,000
Sumble

San Francisco, California, United States

Sumble provides a sales intelligence platform that crawls the web for technographic and contact data.

AppsArtificial Intelligence (AI)Sales
Series AOct 22, 2025
Amount Raised: $30,000,000
Moonlake AI

San Francisco, California, United States

An artificial intelligence research lab building AI models for creating real-time interactive content

SeedOct 1, 2025
Amount Raised: $28,000,000
ALIGNMT AI

New York, New York, United States

ALIGNMT AI is a software company that offers a comprehensive AI governance and risk management platform for healthcare organizations.

Health CareSoftware
SeedAug 28, 2025
Amount Raised: $6,500,000

Therna Biosciences is a medicines development company that specializes in designing RNA therapeutics programme.

BiotechnologyMedicalTherapeutics
SeedAug 26, 2025
Amount Raised: $10,000,000
Tahoe Therapeutics

South San Francisco, California, United States

Tahoe Therapeutics is a biotechnology company that develops AI models of human cells to enhance drug discovery.

Artificial Intelligence (AI)BiotechnologyTherapeutics
Series UnknownAug 11, 2025
Amount Raised: $30,000,000
Coverflow

San Francisco, California, United States

Coverflow is an AI-driven platform for automating insurance processes like policy checking and AMS updates.

Artificial Intelligence (AI)InsurTechSoftwareSoftware Engineering
SeedJul 16, 2025
Amount Raised: $4,800,000
Ryght AI

Laguna Beach, California, United States

Ryght AI develops an enterprise-scale generative AI platform and applications to accelerate clinical trials.

Artificial Intelligence (AI)BiopharmaBiotechnologyClinical TrialsDeveloper PlatformGenerative AIHealth CareSoftware
SeedJun 12, 2025
Amount Raised: $3,000,000

Find More Investors Like AIX Ventures

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

AIX Ventures | Pipeseed